DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Poordad FSW editor LB-7;
All-oral,fixed-dose combination therapy with daclatasvir / asunaprevir / BMS791325 for non-cirrhotic patients with chronic HCV genotype 1 infection: UNITY-1 Phase3 SVR12 results.
AASLD 2014; 2014
Boston:
We do not assume any responsibility for the contents of the web pages of other providers.